Backed by $21M from investors, Raleigh-based Innovate Biopharmaceuticals becomes public company
Innovate Biopharmaceuticals, a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, has completed its reverse merger with California-based Monster Digital and is now a publicly traded company
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed